Advertisement.

LMNL Projected Dividend Yield

Liminal Biosciences Inc ( NASDAQ : LMNL )

Liminal Biosciences is a clinical stage biopharmaceutical company focused on developing distinctive small molecule therapeutics for inflammatory, fibrotic and metabolic diseases using Co.'s drug discovery platform and data-driven approach. Co.'s research and development programs are focused on inflammatory, fibrotic and metabolic conditions in patients with respiratory, liver or renal disease. Co.'s pipeline is made up of three development programs. Co.'s main asset, fezagepras (also known as PBI-4050), a clinical-stage product candidate, as a potential nitrogen scavenger and its GPR84 antagonist and OXER1 antagonist programs, which are preclinical.

20 YEAR PERFORMANCE RESULTS

LMNL Dividend History Detail
LMNL Dividend News
LMNL Competitors News

# of Shares: 0

Closing Price: 8.50

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000